Tech Company Financing Transactions
Nitric BioTherapeutics Funding Round
On 12/31/2010, Nitric BioTherapeutics raised $646 thousand in funding from NewSpring Capital.
Transaction Overview
Company Name
Announced On
12/31/2010
Transaction Type
Venture Equity
Amount
$646,000
Round
Undisclosed
Investors
NewSpring Capital (Zev Scherl)
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Out of Business
Industry
Biopharmaceutical
Mailing Address
2 Canal's End Road 201-A
Bristol, PA 19007
USA
Bristol, PA 19007
USA
Phone
Website
Email Address
Overview
NB Therapeutics is a biopharmaceutical and medical device company focused on developing and commercializing novel and proprietary pharmacologic therapies to address opportunities in the dermatology and podiatry markets with significant unmet needs.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Frank McCaney
Chief Financial Officer
James Ratigan
Chief Operating Officer
Dave Pfeiffer
Chief Technical Officer
Tanya Rhodes
Browse more venture capital transactions:
Prev: 12/31/2010: Mpex Pharmaceuticals venture capital transaction
Next: 12/31/2010: Vascular Designs venture capital transaction
Share this article
Where The Data Comes From
We do our best to record all VC transactions involving tech companies. VC investment data records on this site are sourced from company press releases and news coverage. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs